This results in increased chemokine (C-X3-C motif) ligand 1 (CX3CL1) secretion of macrophages, recruiting more CD4<sup>+</sup> T and NK cells to the tumor site, enhancing the anti-tumor response. This evidence concerns the gene CD4 and neoplasm.